United States
Germany
Japan
United Kingdom
China
Anti-IL-13 Reference Antibody (lebrikizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Antibodies
Anti-IL-13 Reference Antibody (H2L6)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-13 Reference Antibody (M1295)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Rat |
Anti-IL-13 Reference Antibody (GSK 679586)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IL-13 Reference Antibody (IMA-026)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-13 Reference Antibody (anrukinzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IL-13 Reference Antibody (dectrekumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-IL-13 Reference Antibody (cendakimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-13 Reference Antibody (CNTO 607)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-13 Reference Antibody (abrezekimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Rat, Cynomolgus |
Anti-IL-13 Reference Antibody (tralokinumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
